- Home
- RDHL vs BREA Comparison
RDHL vs BREA Comparison
Compare RDHL & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- BREA
- Stock Information
- Founded
- RDHL 2009
- BREA 2022
- Country
- RDHL Israel
- BREA Ireland
- Employees
- RDHL N/A
- BREA N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- RDHL Health Care
- BREA Consumer Discretionary
- Exchange
- RDHL Nasdaq
- BREA Nasdaq
- Market Cap
- RDHL 3.8M
- BREA 13.6M
- IPO Year
- RDHL N/A
- BREA 2023
- Fundamental
- Price
- RDHL $2.03
- BREA $7.55
- Analyst Decision
- RDHL
- BREA
- Analyst Count
- RDHL 0
- BREA 0
- Target Price
- RDHL N/A
- BREA N/A
- AVG Volume (30 Days)
- RDHL 19.2K
- BREA 19.4K
- Earning Date
- RDHL 04-10-2025
- BREA 01-01-0001
- Dividend Yield
- RDHL N/A
- BREA N/A
- EPS Growth
- RDHL N/A
- BREA N/A
- EPS
- RDHL N/A
- BREA N/A
- Revenue
- RDHL $8,042,999.00
- BREA $2,988,009.00
- Revenue This Year
- RDHL $381.91
- BREA N/A
- Revenue Next Year
- RDHL N/A
- BREA N/A
- P/E Ratio
- RDHL N/A
- BREA N/A
- Revenue Growth
- RDHL 23.17
- BREA 151.51
- 52 Week Low
- RDHL $1.71
- BREA $5.00
- 52 Week High
- RDHL $20.28
- BREA $19.50
- Technical
- Relative Strength Index (RSI)
- RDHL 57.04
- BREA 58.43
- Support Level
- RDHL $1.75
- BREA $5.90
- Resistance Level
- RDHL $2.08
- BREA $7.78
- Average True Range (ATR)
- RDHL 0.09
- BREA 0.68
- MACD
- RDHL 0.03
- BREA 0.07
- Stochastic Oscillator
- RDHL 85.16
- BREA 91.00
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.